Covered recipient · General Payments record
CHARLES RAYMOND BRADFORD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,479.09
- Reported across 519 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.58 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $81.69 | 4 |
| Novo Nordisk AS | $51.88 | 3 |
| PFIZER INC. | $38.52 | 2 |
| Corcept Therapeutics | $28.20 | 1 |
| Astellas Pharma US Inc | $22.32 | 1 |
| DEXCOM, INC. | $21.61 | 1 |
| Acerta Pharma LLC | $20.56 | 1 |
| Amgen Inc. | $15.12 | 1 |
| Exact Sciences Corporation | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.75 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103360055 | CMS |
| ABBVIE INC. | $21.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103360057 | CMS |
| ABBVIE INC. | $20.94 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103360059 | CMS |
| ABBVIE INC. | $14.96 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103360061 | CMS |
| Amgen Inc. | $15.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117208654 | CMS |
| Astellas Pharma US Inc | $22.32 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139292956 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.56 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105491181 | CMS |
| Corcept Therapeutics | $28.20 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117760546 | CMS |
| Dexcom, Inc. | $21.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153291011 | CMS |
| Exact Sciences Corporation | $14.68 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114597759 | CMS |
| Novo Nordisk Inc | $18.21 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096992063 | CMS |
| Novo Nordisk Inc | $17.24 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096745836 | CMS |
| Novo Nordisk Inc | $16.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096679224 | CMS |
| PFIZER INC. | $20.58 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130988036 | CMS |
| PFIZER INC. | $17.94 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131120068 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.